PMID: 6104992May 1, 1980Paper

Role of the sympathetic nervous system in the pathogenesis of experimental glaucoma

Biulleten' eksperimental'noĭ biologii i meditsiny
G N KryzhanovskiĭO P Kopp

Abstract

It has been shown in experiments on rabbits that alpha-and beta-adrenoblockers, and lithium chloride solution exert different effect on intraocular tension of healthy animals with experimental glaucoma and transitory hypertension. The beta-blockker obsidan decreases the tension in experimental glaucoma. Pretreatment with the drug prevents the development of glaucoma. On the contrary, the alpha-blocker pirroxan promotes the development of glaucoma and does not elicit any hypotensive therapeutic effect. The drug-induced decrease in intraocular tension was recorded in healthy animals and in rabbits with transitory hypertensin of the eye. The hypotensive effect of lithium was noted only in the animals with experimental glaucoma. The role of alpha-and beta-adrenergic receiption in the pathogenesis of glaucoma is discussed.

References

Apr 1, 1988·Biulleten' eksperimental'noĭ biologii i meditsiny·V N ErmakovaA Ia Bunin
May 1, 1969·Teratology·B V Konyukhov, M P Vakhrusheva
Jan 1, 1966·Life Sciences·A E Needham

❮ Previous
Next ❯

Citations

Jan 1, 1984·Biulleten' eksperimental'noĭ biologii i meditsiny·Iu G Grigor'ev, O A Timofeeva
Jan 1, 1992·Neir̆ofiziologiia = Neurophysiology·E A Makiĭ, I Ia Serdiuchenko
Nov 1, 1983·Neuroscience and Behavioral Physiology·G N KryzhanovskiiA A Shandra
May 1, 1993·Neuroscience and Behavioral Physiology·N N Bogolepov
Mar 1, 1984·Neuroscience and Behavioral Physiology·E I Mukhin
May 1, 1985·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭL S Godlevskiĭ
Aug 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·V E BraslavskiĭS B Germanov
Aug 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭT V Speranskaia
Dec 1, 1987·Biulleten' eksperimental'noĭ biologii i meditsiny·A P ChuprikovA I Gladkikh
May 1, 1988·Biulleten' eksperimental'noĭ biologii i meditsiny·V V ShkolovoĭR N Glebov
Apr 1, 1984·Biulleten' eksperimental'noĭ biologii i meditsiny·L G MillerG N Kryzhanovskiĭ
Dec 1, 1986·Biulleten' eksperimental'noĭ biologii i meditsiny·L N NerobkovaG N Kryzhanovskiĭ
Dec 1, 1986·Biulleten' eksperimental'noĭ biologii i meditsiny·N A Agadzhanian, V I Torshin
Oct 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·L M NepomniashchikhV P Tumanov
Mar 1, 1983·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭL S Godlevskiĭ
Jul 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭV A Zinkevich
Jul 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭN G Lutsenko
Mar 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·V K ReshetniakR A Durinian
Jan 1, 1984·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryshanovskiĭE I Danilova
May 1, 1989·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭL N Nerobkova
Sep 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭV S Smirnova
Feb 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭI I Mikhaleva
Jun 1, 1987·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭV S Rozhkov
Jul 1, 1987·Biulleten' eksperimental'noĭ biologii i meditsiny·M N KarpovaO L Agatova
Jan 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭA D Mazarati
Jan 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·N N Karkishchenko, E A Bardakhch'ian
Jun 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·N A AgadzhanianA I Elfimov
Jun 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭA M Mazarati
Jan 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭM Iu Karganov
Dec 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·V A VoronkoS B Germanov
Oct 1, 1985·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭI N Moiseev
Sep 1, 1985·Biulleten' eksperimental'noĭ biologii i meditsiny·V N Grafova, E I Danilova
Mar 1, 1985·Biulleten' eksperimental'noĭ biologii i meditsiny·S L BuldakovaV G Skrebitskiĭ
Oct 1, 1983·Biulleten' eksperimental'noĭ biologii i meditsiny·O A Timofeeva
May 1, 1990·Biulleten' eksperimental'noĭ biologii i meditsiny·G I KryzhanovskiĭT V Speranskaia
Apr 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·O Iu LaurA I Ivanenko
Jul 1, 1981·Biulleten' eksperimental'noĭ biologii i meditsiny·A A Shandra, L S Godlevskiĭ
Jul 1, 1981·Biulleten' eksperimental'noĭ biologii i meditsiny·G N KryzhanovskiĭE I Danilova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.